ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Short Interest Update

ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) was the target of a significant decrease in short interest in August. As of August 31st, there was short interest totalling 8,700 shares, a decrease of 5.4% from the August 15th total of 9,200 shares. Based on an average daily trading volume, of 13,900 shares, the days-to-cover ratio is presently 0.6 days.

Hedge Funds Weigh In On ProShares Ultra Nasdaq Biotechnology

Several hedge funds have recently bought and sold shares of BIB. IMC Chicago LLC acquired a new stake in shares of ProShares Ultra Nasdaq Biotechnology during the 4th quarter worth approximately $2,435,000. Clarity Capital Partners LLC bought a new position in shares of ProShares Ultra Nasdaq Biotechnology in the 4th quarter valued at $201,000. Toth Financial Advisory Corp raised its holdings in shares of ProShares Ultra Nasdaq Biotechnology by 132.3% during the 1st quarter. Toth Financial Advisory Corp now owns 26,111 shares of the exchange traded fund’s stock worth $1,502,000 after buying an additional 14,870 shares in the last quarter. Westwood Wealth Management bought a new stake in shares of ProShares Ultra Nasdaq Biotechnology during the 1st quarter worth $575,000. Finally, Texas Capital Bank Wealth Management Services Inc bought a new stake in shares of ProShares Ultra Nasdaq Biotechnology during the 1st quarter worth $288,000.

ProShares Ultra Nasdaq Biotechnology Stock Down 0.9 %

Shares of NASDAQ BIB opened at $66.68 on Thursday. The business has a fifty day moving average price of $65.29 and a two-hundred day moving average price of $59.29. ProShares Ultra Nasdaq Biotechnology has a fifty-two week low of $40.10 and a fifty-two week high of $69.56.

ProShares Ultra Nasdaq Biotechnology Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, July 3rd. Shareholders of record on Wednesday, June 26th were paid a dividend of $0.2648 per share. This represents a $1.06 dividend on an annualized basis and a yield of 1.59%. This is an increase from ProShares Ultra Nasdaq Biotechnology’s previous quarterly dividend of $0.04. The ex-dividend date was Wednesday, June 26th.

About ProShares Ultra Nasdaq Biotechnology

ProShares Ultra Nasdaq Biotechnology (the Fund) seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from the inverse of the return of the Dow Jones United States Basic Materials Index (the Index) for that period.